Comparison of secukinumab and adalimumab biosimilar on radiographic progression in ankylosing spondylitis patients: Design of a randomized, phase‐IIIb study (SURPASS)

X Baraliakos; Mikkel Østergaard; L S Gensler; D Poddubnyy; E Y Lee; U Kiltz; R Martin; H Sawata; A Readie; B Porter

Comparison of secukinumab and adalimumab biosimilar on radiographic progression in ankylosing spondylitis patients: Design of a randomized, phase‐IIIb study (SURPASS)

X Baraliakos
, Mikkel Østergaard
, L S Gensler
, D Poddubnyy
, E Y Lee
, U Kiltz
, R Martin
, H Sawata
, A Readie
, B Porter

Department for Rheumatology and Spine Diseases

Original language	English
Article number	SU147
Journal	International Journal of Rheumatic Diseases
Volume	21
Issue number	S1
Pages (from-to)	121-122
Number of pages	2
ISSN	1756-1841
Publication status	Published - 2018

Cite this

Baraliakos, X., Østergaard, M., Gensler, L. S., Poddubnyy, D., Lee, E. Y., Kiltz, U., Martin, R., Sawata, H., Readie, A., & Porter, B. (2018). Comparison of secukinumab and adalimumab biosimilar on radiographic progression in ankylosing spondylitis patients: Design of a randomized, phase‐IIIb study (SURPASS). International Journal of Rheumatic Diseases, 21(S1), 121-122. Article SU147.

Comparison of secukinumab and adalimumab biosimilar on radiographic progression in ankylosing spondylitis patients: Design of a randomized, phase‐IIIb study (SURPASS). / Baraliakos, X; Østergaard, Mikkel; Gensler, L S et al.
In: International Journal of Rheumatic Diseases, Vol. 21, No. S1, SU147, 2018, p. 121-122.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Baraliakos, X, Østergaard, M, Gensler, LS, Poddubnyy, D, Lee, EY, Kiltz, U, Martin, R, Sawata, H, Readie, A & Porter, B 2018, 'Comparison of secukinumab and adalimumab biosimilar on radiographic progression in ankylosing spondylitis patients: Design of a randomized, phase‐IIIb study (SURPASS)', International Journal of Rheumatic Diseases, vol. 21, no. S1, SU147, pp. 121-122.

@article{c63bbf560a8046d6aac2cf7e0ed4f118,

title = "Comparison of secukinumab and adalimumab biosimilar on radiographic progression in ankylosing spondylitis patients: Design of a randomized, phase‐IIIb study (SURPASS)",

author = "X Baraliakos and Mikkel {\O}stergaard and Gensler, \{L S\} and D Poddubnyy and Lee, \{E Y\} and U Kiltz and R Martin and H Sawata and A Readie and B Porter",

note = "COPECARE",

year = "2018",

language = "English",

volume = "21",

pages = "121--122",

journal = "International Journal of Rheumatic Diseases",

issn = "1756-1841",

publisher = "John Wiley and Sons Inc.",

number = "S1",

}

TY - ABST

T1 - Comparison of secukinumab and adalimumab biosimilar on radiographic progression in ankylosing spondylitis patients: Design of a randomized, phase‐IIIb study (SURPASS)

AU - Baraliakos, X

AU - Østergaard, Mikkel

AU - Gensler, L S

AU - Poddubnyy, D

AU - Lee, E Y

AU - Kiltz, U

AU - Martin, R

AU - Sawata, H

AU - Readie, A

AU - Porter, B

N1 - COPECARE

PY - 2018

Y1 - 2018

M3 - Conference abstract in journal

SN - 1756-1841

VL - 21

SP - 121

EP - 122

JO - International Journal of Rheumatic Diseases

JF - International Journal of Rheumatic Diseases

IS - S1

M1 - SU147

ER -